Central Diabetes Insipidus
8
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
38%
3 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls
Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls
Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in Children
Identification and Clinical Relevance of an Oxytocin Deficient State (Melatonin Study)
Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)
Seoul National University Pituitary Disease Cohort Study
A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).